Lara Smith-Weber
President bei CONSTELLATION PHARMACEUTICALS, INC.
Profil
Lara Smith-Weber is currently the President, Secretary & Treasurer at Constellation Pharmaceuticals, Inc. She previously worked as Senior VP-Controlling & Internal Controlling at MorphoSys AG, Head-Financial Planning & Analysis at MorphoSys US, Inc., and Chief Financial Officer at Onward Medical NV.
Ms. Smith-Weber received her undergraduate and graduate degrees from Stanford University and an MBA from the International Institute for Management Development.
Aktive Positionen von Lara Smith-Weber
| Unternehmen | Position | Beginn |
|---|---|---|
| CONSTELLATION PHARMACEUTICALS, INC. | President | 15.07.2021 |
Ehemalige bekannte Positionen von Lara Smith-Weber
| Unternehmen | Position | Ende |
|---|---|---|
| ONWARD MEDICAL N.V. | Director of Finance/CFO | 01.10.2023 |
| MorphoSys US, Inc. | Corporate Officer/Principal | - |
| MORPHOSYS AG | Comptroller/Controller/Auditor | - |
Ausbildung von Lara Smith-Weber
| Stanford University | Graduate Degree |
| International Institute for Management Development | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| MORPHOSYS AG | Health Technology |
| ONWARD MEDICAL N.V. | Commercial Services |
| Private Unternehmen | 2 |
|---|---|
Constellation Pharmaceuticals, Inc.
 Constellation Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Constellation Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of novel therapeutics in the field of epigenetics. The firm utilizes epigenetics platform, which enables to validate targets and generate small molecules against these targets that selectively modulate gene expression in tumor and immune cells to drive anti-tumor activity. Its product include CPI-0610, CPI-1205, and CPI-0209. The company was founded by Danny Reinberg, David Allis, and Yang Shi on January 11, 2008 and is headquartered in Cambridge, MA. | Health Technology |
| MorphoSys US, Inc. |
